HYDERABAD, India--(BUSINESS WIRE)--Jan. 7, 2004--Dr. Reddy’s Laboratories (NYSE:RDY - News) today announced that it is scheduled to present at the 22nd Annual JP Morgan Healthcare Conference, which is scheduled to be held in San Francisco, on Thursday January 14, 2004, at 9:00 A.M. ET
The presentation will be web cast live and can be accessed from the Company’s website at www.drreddys.com. The replay of the web cast will be archived for 90 days immediately following the presentation.
About Dr. Reddy’s
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY - News) is an emerging global pharmaceutical company with proven basic research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia. The Company conducts research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection.
This press release includes forward-looking statements, as defined in the U.S. Private Securities Litigation Reform Act of 1995. We have based these forward-looking statements on our current expectations and projections about future events. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. Such factors include, but are not limited to, changes in local and global economic conditions, our ability to successfully implement our strategy, the market acceptance of and demand for our products, our growth and expansion, technological change and our exposure to market risks. By their nature, these expectations and projections are only estimates and could be materially different from actual results in the future.
Contact:
Dr. Reddy’s Laboratories Nikhil Shah, +91-40-55511532 nikhilshah@drreddys.com
Source: Dr. Reddy’s Laboratories
